Blog
RSS FeedPosted by Michael Wonder on 28 May 2020
TLV has decided to reconsider the subsidy status for certain drugs
26 May 2020 - TLV initiates a review for review of subsidy status for drugs that are part of one ...
Posted by Michael Wonder on 06 May 2020
Half yearly performance snapshot: July to December 2019
6 May 2020 - The TGA prepares an annual TGA Business Plan, which identifies the priority activities being undertaken over the ...
Posted by Michael Wonder on 30 Apr 2020
EMA starts rolling review of remdesivir for COVID-19
30 April 2020 - EMA’s human medicines committee (CHMP) has started a ‘rolling review’ of data on the use of ...
Posted by Michael Wonder on 21 Apr 2020
Pharmacists welcome medicine review update
21 April 2020 - Elderly people at risk of medicine-related harm will now have their treatments more regularly reviewed by ...
Posted by Michael Wonder on 14 Apr 2020
Pharmacologic treatments for coronavirus disease 2019 (COVID-19): a review
13 April 2020 - The pandemic of coronavirus disease 2019 (COVID-19) caused by the novel severe acute respiratory syndrome coronavirus 2 ...
Posted by Michael Wonder on 03 Apr 2020
The review shows that it is possible to lower the cost of medicines
3 April 2020 - There are opportunities to make savings on medicines. ...
Posted by Michael Wonder on 26 Feb 2020
Independent review of the reforms to the therapeutic goods advertising framework to commence
26 February 2020 - The independent review of the advertising reforms has now commenced, and is being led by Ms Rosemary ...
Posted by Michael Wonder on 20 Feb 2020
Serving public health paramount in a successful 2019 for FDA’s generic drug program
19 February 2020 - Safe, effective, high-quality generic drugs play a vital role in the U.S. health care system. ...
Posted by Michael Wonder on 28 Jan 2020
TLV is reviewing the subsidy of factor VIII drugs with side agreements
28 January 2020 - Factor VIII drugs are used to treat a form of hemorrhagic disease, hemophilia A, which involves ...
Posted by Michael Wonder on 15 Jan 2020
Reform at the FDA—in need of reform
14 January 2020 - On 23 December 2016, the US FDA announced the approval of nusinersen, the first drug for the ...
Posted by Michael Wonder on 15 Jan 2020
TLV has decided to reconsider the subsidy for Xeljanz
14 January 2020 - When TLV decided that Xeljanz should be included in the high-cost protection, this was justified by the ...
Posted by Michael Wonder on 09 Jan 2020
Human medicines: highlights of 2019
9 January 2020 - EMA has published a review of its key recommendations in 2019 on the authorisation and safety ...
Posted by Michael Wonder on 08 Jan 2020
PBAC – 2019 in review
8 January 2020 - The PBAC considered 188 submissions in 2019. ...
Posted by Michael Wonder on 06 Jan 2020
Novel drug approvals for 2019
2 January 2020 - How many of the 'novel' drugs approved by the FDA in 2019 are actually new medicines in ...
Posted by Michael Wonder on 03 Dec 2019
The use of risk-sharing contracts in health care: theoretical and empirical assessments
3 December 2019 - The aim of this review is to provide a summary of the literature on risk-sharing agreements, including ...